章津銘
個(gè)人簡(jiǎn)介：
章津銘，教授，現(xiàn)任成都中醫(yī)藥大學(xué)藥學(xué)院/現(xiàn)代中藥產(chǎn)業(yè)學(xué)院副院長(zhǎng)。主要研究方向?yàn)橹兴幮滦图{米遞藥系統(tǒng)及中醫(yī)藥健康產(chǎn)品開(kāi)發(fā)。省部級(jí)優(yōu)秀人才計(jì)劃入選者、中國(guó)科協(xié)第四屆青年人才托舉工程人選、四川省杰出青年科技人才、四川省“特聘專家”、四川省中醫(yī)藥管理局學(xué)術(shù)技術(shù)帶頭人，榮獲全國(guó)高等中醫(yī)藥院校優(yōu)秀青年、四川省優(yōu)秀黨務(wù)工作者、四川省五四青年教師榜樣等榮譽(yù)。承擔(dān)國(guó)家自然科學(xué)基金面上項(xiàng)目基金、青年科學(xué)基金、中國(guó)博士后科學(xué)基金面上資助項(xiàng)目、中國(guó)博士后科學(xué)基金特別資助項(xiàng)目、四川省杰出青年科技人才項(xiàng)目等國(guó)家級(jí)、省部級(jí)等項(xiàng)目。以第一作者或通訊作者在Adv Drug Deliv Rev、Acta Pharm Sin B、Theranostics等學(xué)術(shù)期刊發(fā)表SCI論文100余篇，入選2020年度、2022年度“全球前2%頂尖科學(xué)家榜單”（藥學(xué)領(lǐng)域）（H-index 35），獲授權(quán)發(fā)明專利8項(xiàng)，參與編寫(xiě)教材及專著多部，擔(dān)任Chin Chem Lett、Chin Med、iMeta等期刊青年編委，中華中醫(yī)藥學(xué)會(huì)第二屆青年委員會(huì)委員、世中聯(lián)中藥新型給藥系統(tǒng)專業(yè)委員會(huì)常務(wù)理事等。
部分代表性成果如下：
1. Quan Gao, Jiao Feng, Wencheng Liu, Chengyong Wen, Yihan Wu, Qian Liao, Liang Zou, Xinbing Sui, Tian Xie, Jinming Zhang*, Yichen Hu*. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment[J]. Adv Drug Deliv Rev. 2022, 188: 114445.
2. Yihan Wu, Jiaxin Li, Liang Zou, Chaomei Fu, Meiwan Chen, Jinming Zhang*, Huile Gao. A pH-sensitive supramolecular nanosystem with chlorin e6 and triptolide co-delivery for chemo-photodynamic combination therapy[J]. Asian J Pharm Sci. 2022, 17(02): 206-218.
3. Qian Liao, Lan Pang, Jing-Jing Li, Chen Zhang, Jia-Xing Li, Xing Zhang, Ting Mao, Ding-Tao Wu, Xiu-Ying Ma, Fu-Neng Geng, Jin-Ming Zhang*. Characterization and diabetic wound healing benefits of protein-polysaccharide complexes isolated from an animal ethno-medicine Periplaneta americana L[J]. Int J Biol Macromol. 2022, 195: 466-474.
4. Jinfeng Shi#, Yali Ren#, Jiaqi Ma, Xi Luo, Jiaxin Li, Yihan Wu, Huan Gu, Chaomei Fu, Zhixing Cao*, Jinming Zhang*. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis[J]. J Nanobiotechnology. 2021, 19(01): 188.
5. Xiao Wang, Huan Gu, Huan Zhang, Jing Xian, Jingjing Li, Chaomei Fu, Chen Zhang, Jinming Zhang*. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy[J]. ACS Appl Mater Interfaces. 2021, 13(29): 33948-33961.
6. Liang Zou , Xiaowei Liu, Jingjing Li, Wei Li, Lele Zhang, Chaomei Fu, Jinming Zhang?, Zhongwei Gu?. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy [J]. Theranostics, 2021, 11(09): 4171.
7. Yaoyao Luo#, Jingjing Li#, Yichen Hu, Fei Gao, George Pak-Heng Leung, Funeng Geng, Chaomei Fu*, Jinming Zhang*. Injectable thermo-responsive nano-hydrogel loading triptolide for the anti-breast cancer enhancement via localized treatment based on “two strikes” effects[J]. Acta Pharm Sin B, 2020, 10(11): 2227-2245.
8. Xiaoqin Yang, Yihan Wu, Chen Zhang, Shu Fu, Jinming Zhang*, Fu Chaomei*. Extraction, structural characterization, and immunoregulatory effect of a polysaccharide fraction from Radix Aconiti Lateralis Preparata (Fuzi)[J]. Int J Biol Macromol, 2020, 143: 314-324.
9. Jingjing Li#, Yihan Wu#, Di Wang, Liang Zou, Chaomei Fu, Jinming Zhang*, Leung George Pak-Heng*. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects[J]. Pharmacol Res, 2019, 146: 104313.
10. Jinming Zhang, Jingjing Li, Zhi Shi, Yang Yang, Xi Xie, Simon MingYuen Lee*, Yitao Wang, Kam W Leong, Meiwan Chen*. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities[J]. Acta Biomaterialia, 2017, 58: 349-364.